Clinuvel Pharmaceuticals Ltd. (CUVL)
6.01
-0.51
(-7.82%)
USD |
NASDAQ |
Sep 08, 16:00
6.07
+0.06
(+1.00%)
Pre-Market: 20:00
Clinuvel Pharmaceuticals Max Drawdown (5Y) : 80.74% for Aug. 31, 2026
Max Drawdown (5Y) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Max Drawdown (5Y) Data
| Date | Value |
|---|---|
| August 31, 2026 | 80.74% |
| July 31, 2026 | 80.02% |
| June 30, 2026 | 80.02% |
| May 31, 2026 | 80.02% |
| April 30, 2026 | 80.02% |
| March 31, 2026 | 80.02% |
| February 28, 2026 | 80.02% |
| January 31, 2026 | 80.02% |
| December 31, 2025 | 80.02% |
| November 30, 2025 | 80.02% |
| October 31, 2025 | 80.02% |
| September 30, 2025 | 80.02% |
| August 31, 2025 | 80.02% |
| July 31, 2025 | 80.02% |
| June 30, 2025 | 80.02% |
| May 31, 2025 | 80.02% |
| April 30, 2025 | 80.02% |
| March 31, 2025 | 77.80% |
| February 28, 2025 | 77.80% |
| January 31, 2025 | 77.80% |
| December 31, 2024 | 75.86% |
| November 30, 2024 | 72.96% |
| October 31, 2024 | 72.96% |
| September 30, 2024 | 72.96% |
| August 31, 2024 | 72.96% |
| Date | Value |
|---|---|
| July 31, 2024 | 72.58% |
| June 30, 2024 | 72.58% |
| May 31, 2024 | 72.58% |
| April 30, 2024 | 72.58% |
| March 31, 2024 | 72.58% |
| February 29, 2024 | 72.16% |
| January 31, 2024 | 71.49% |
| December 31, 2023 | 71.49% |
| November 30, 2023 | 71.49% |
| October 31, 2023 | 71.49% |
| September 30, 2023 | 70.12% |
| August 31, 2023 | 70.12% |
| July 31, 2023 | 70.12% |
| June 30, 2023 | 70.12% |
| May 31, 2023 | 70.12% |
| April 30, 2023 | 70.12% |
| March 31, 2023 | 70.12% |
| February 28, 2023 | 70.12% |
| January 31, 2023 | 70.12% |
| December 31, 2022 | 70.12% |
| November 30, 2022 | 70.12% |
| October 31, 2022 | 70.12% |
| September 30, 2022 | 70.12% |
| August 31, 2022 | 70.12% |
| July 31, 2022 | 70.12% |
Max Drawdown Definition
Max drawdown is an indicator of the risk of a portfolio chosen based on a certain strategy. It measures the largest single drop from peak to bottom in the value of a portfolio before a new peak is achieved.
Max Drawdown (5Y) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Max Drawdown (5Y) Benchmarks
| Alterity Therapeutics Ltd. | 96.94% |
| Kazia Therapeutics Ltd. | 99.58% |
| Algorae Pharmaceuticals Ltd. | 98.33% |
| Immuron Ltd. | 92.60% |
| Amplia Therapeutics Ltd. | 99.29% |
Max Drawdown (5Y) Related Metrics
| Alpha (5Y) | -36.91 |
| Beta (5Y) | 0.7969 |
| Annualized Standard Deviation of Monthly Returns (5Y Lookback) | 42.53% |
| Historical Sharpe Ratio (5Y) | -0.6978 |
| Historical Sortino (5Y) | -1.284 |
| Monthly Value at Risk (VaR) 5% (5Y Lookback) | 19.98% |